Thermo Fisher Scientific (TMO) Change in Accured Expenses (2009 - 2019)

Thermo Fisher Scientific has disclosed Change in Accured Expenses across 11 years of filings, most recently posting $38.0 million for Q4 2019.

• Quarterly Change in Accured Expenses fell 75.8% year-over-year to $38.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $210.0 million (up 600.0% YoY) and the FY2019 annual result came in at $210.0 million, up 600.0% from the prior year.
• Change in Accured Expenses advanced to $38.0 million in Q4 2019, from -$147.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $992.0 million in Q4 2017 and troughed at -$471.0 million in Q1 2018.
• A 5-year average of $80.0 million and a median of $115.2 million in 2015 frame the typical range for Change in Accured Expenses.
• Biggest YoY gain for Change in Accured Expenses was 12019.44% in 2015; the steepest drop was 247.98% in 2015.
• Tracing TMO's Change in Accured Expenses over 5 years: stood at $436.3 million in 2015, then decreased by 16.89% to $362.6 million in 2016, then surged by 173.58% to $992.0 million in 2017, then slumped by 84.17% to $157.0 million in 2018, then plunged by 75.8% to $38.0 million in 2019.
• Business Quant data shows TMO's Change in Accured Expenses at $38.0 million in Q4 2019, -$147.0 million in Q3 2019, and $549.0 million in Q2 2019.